期刊文献+

血管内皮生长因子基因多态性与2型糖尿病视网膜病变相关性的Meta分析 被引量:7

A Meta-analysis of correlation between the polymorphism of vascular endothelial growth factor(VEGF) and diabetic retinopathy in type Ⅱ diabetes
下载PDF
导出
摘要 目的利用Meta分析探讨血管内皮生长因子1(Vascular endothelial growth factor,VEGF)基因多态性与2型糖尿病视网膜病变的相关性。方法电子检索CNKI、万方及Pub Med数据库,收集有关VEGF936C/T及VEGF 460C/T基因多态性与2型糖尿病视网膜病变的病例对照研究。检索时间为建库至2013年9月。采用Rev Man5.0软件进行Meta分析。结果共纳入9个研究,其中5个研究的是VEGF 936C/T多态性与2型糖尿病视网膜病变的关系,4个研究的是VEGF 460C/T与2型糖尿病视网膜病变的关系。Meta分析结果显示:具有VEGF 460TT基因型[OR=0.31,95%CI(0.19,0.50),P<0.01],CT基因型[OR=0.67,95%CI(0.46,0.98),P=0.04]及TT+CT基因型[OR=0.43,95%CI(0.27,0.69),P=0.0005]的人群发生2型糖尿病视网膜病变的风险明显低于具有基因型CC的人群,另外VEGF 460T等位基因携带者2型糖尿病视网膜病变发病风险低于等位基因C携带者[OR=0.67,95%CI(0.55,0.81),P<0.01]。而VEGF 936C/T多态性在病例组和对照组分析差异无统计学意义(P>0.05)。结论 VEGF 460C/T基因多态性与2型糖尿病视网膜病变发病相关,VEGF 460C/T基因可能是2型糖尿病视网膜病变的遗传保护因素。 OBJECTIVE To investigate the association between the polymorphism of Vascular endothelial growth factor(VEGF) gene and susceptibility of diabetic retinopathy(DR) among patients with type 2 diabetes mellitus(T2DM)via meta-analysis. METHODS An electronically search based on CNKI,Wanfang database and Pub Med from their establishment to January 2013 was performed to collect case-control studies on VEGF 936C/T and VEGF 460C/T polymorphism and DR in T2 DM. Rev Man5.0 was used for this study. RESULTS Nine case-control studies were identified(five eligible studies were analyzed for VEGF 936C/T polymorphism and DR in T2 DM and fore were analyzed for VEGF 460C/T polymorphism and DR in T2DM) on association of VEGF polymorphism and DR in T2 DM. The results of meta-analysis showed that the population having the genotype VEGF 460 TT [OR=0.31,95% CI(0.19,0.50),P〈0.00001],genotype CT [OR =0.67,95% CI(0.46,0.98)and TT +CT [OR =0.43,95% CI(0.27,0.69),P=0.0005] presented an decreased DR risk compared to that with the genotypes CC. Moreover the al lele T showed significant association with decreased DR risk compared to the allele C [OR=0.67,95%CI(0.55,0.81),P 〈0.00001]. While,no significant association was observed on the VEGF 936C/T polymorphism and DR in T2DM(P〉0.05). CONCLUSIONS VEGF 460C/T polymorphisms was associated with DR in T2 DM and VEGF 460C/T variation which might be a genetic protective factor for DR in T2 DM.
作者 马俊起
出处 《中国中医眼科杂志》 2015年第1期46-49,共4页 China Journal of Chinese Ophthalmology
关键词 糖尿病 视网膜病变 血管内皮生长因子 基因多态性 META分析 diabetes mellitus diabetic retinopathy vascular endothelial growth factor polymorphism meta-analysis
  • 相关文献

参考文献12

  • 1Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5"-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes[J]. Diabetes, 2002,51 (5) : 1635-1639.
  • 2Penn JS, Madan A, Caldwell RB, et al. Vascular endothelial growth factor in eye disease[J]. Prog Retin Eye Res ,2008,27 (4) :331-371.
  • 3Wirostko B,Wong TY,Simo R. Vascular endothelial growth factor and diabetic complications [J]. Prog Retin Eye Res, 2008,27 (6) : 608-621.
  • 4Rennet W, Kotschan S, Hoffmann C,et al. A common 936 crI' muta- tion in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levcls[J].J Vase Res, 2000,37(6) :443-448.
  • 5Watson CJ ,Webb N J, Bottomley MJ,ct al. Identification of polymor- phisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein produetion[J-].Cytokine, 2000,12(8) : 1232-1235.
  • 6Paine SK,Basu A,Mondal LK,et al. Association of vascular en- dothelial growth factor,transforming growth factor beta,and inter- feron gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes[J]. Mol Vis ,2012,18: 2749-2757.
  • 7Yang X, Deng Y, Gu H, et 8]. Polymorphisms in the vascular en- dothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes[J]. Mol Vis, 2011,17 : 3088- 3096.
  • 8张新焕,邓仰欣,石昌红,牛铭云,丁鹤林.血管内皮生长因子3’非翻译区936C/T突变与糖尿病视网膜病变的关系[J].中国病理生理杂志,2011,27(7):1366-1371. 被引量:4
  • 9Kim HW, Ko GJ, Kang YS, et al. Role of the VEGF 936 C/T poly- morphism in diabetic microvascular complications in type 2 diabetic patients[J].Nephrology (Carlton) ,2009,14(7) :681-688.
  • 10Uthra S,Raman R,Mukesh BN,et al. Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort[J]. Ophthalmic Genet, 2008,29 ( 1 ) : 11-15.

二级参考文献18

  • 1Awata T,Inoue J,Kurihara S, et al. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes, 2002, 51:1635-1639.
  • 2Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes, 1999,48: 1899-1906.
  • 3Witmer AN,Vrensen GF,Van Noorden CJ,et al. Vascular endothelial growth factor and angiogenesis in eye disease. Prog Eye Res,2003,22:1-29.
  • 4Ray D,Mishra M, Ralph S, et al. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes, 2004,53 : 861-864.
  • 5Watson CJ, Webb NJ, Bottomeley MJ, et al. Indentification of polymorphism within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine, 2000,12 : 1232-1235.
  • 6Kim HW,Ko GJ,Kang YS,et al.Role of theVEGF936C/Tpolymorphism in diabetic microvascular complicationsin type 2 diabetic patients. Nephrology(Carlton) . 2009
  • 7Mahdy RA,Nada WM.Evaluation of the role of vascularendothelial growth factor in diabetic retinopathy. Oph-thalmic Res . 2011
  • 8Iruela-Arispe M L,Dvorak H F.Angiogenesis: a dynamic balance of stimulators and inhibitors. Thrombosis and Haemostasis . 1997
  • 9Chowdhury TA,Dyer PH,Kumar S,et al.Genetic determinants of diabetic nephropathy. Clinical Science . 1999
  • 10Watson CJ,Webb NJ,Bottomley MJ,et al.Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine . 2000

共引文献6

同被引文献120

  • 1金立,赵文杰,车立群,张伟,吴迪.高压氧治疗2型糖尿病单纯型视网膜病变的价值[J].中国老年学杂志,2014,34(10):2645-2647. 被引量:9
  • 2Shi L, Wu H, Dang J, Jiang K, et al. Telemedicine for detecting diabetic retinopathy : a systematic review and meta-analysis [ J ]. Br J Ophthalmol, 2015,99 ( 6 ) : 823-831. DOI : 10.1136/bjoph- thalmol-2014-305631.
  • 3Osaadon P, Fagan X J, Lifshitz T,et al. A review of anti-VEGF a- gents for proliferative diabetic retinopathy [ J ]. Eye ( Lond ), 2014,28 (5) :510-520. DOI:10. 1038/eye. 2014.13.
  • 4Holla S, Balaji KN. Epigenetics and miRNA during bacteria-in- duced host immune responses [ J ]. Epigenomics, 2015,7 ( 7 ) : 1197-1212. DOI : 10. 2217/epi. 15.75.
  • 5Qing S,Yuan S,Yun C ,et al. Serum miRNA biomarkers serve asa fingerprint for proliferative diabetic retinopathy [ J ]. Cell Physiol Biochem,2014,34 (5) : 1733-1740. DOI : 10.1159/000366374.
  • 6Xu Y, Cheng Q, Yang B, et al. Increased sCD200 levels in vitre- ous of patients with proliferative diabetic retinopathy and its cor- relation with VEGF and proinflammatory cytokines ~ J ]. Invest Ophthalmol Vis Sci, 2015,56 ( 11 ) : 6565-6572. DOI : 10. 1167/ iovs. 15-16854.
  • 7Hong F, Li Y, Xu Y. Decreased placental miR-126 expression and vascular endothelial growth factor levels in patients with pre-ec- lampsia[ J]. J Int Med Res,2014,42 (6) : 1243-1251. DOI: 10. 1177/0300060514540627.
  • 8Liu Y, Gao G, Yang C, et al. The role of circulating microRNA- 126 (miR-126) :a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus [ J ]. Int J Mol Sci, 2014,15 ( 6 ) : 10567-10577. DOI : 10. 3390/ijms150610567.
  • 9Marina ME, Roman II, Constantin AM, et al. VEGF involvement in psoriasis[ J ]. Clujul Med, 2015,88 ( 3 ) : 247-252. DOI : 10. 15386/cjmed-494.
  • 10Bai Y, Bai X, Wang Z, et al. MicroRNA-126 inhibits ischemia-in- duced retinal neovascularization via regulating angiogenic growth factors[ J]. Exp Mol Pathol, 2011,91 ( 1 ) :471-477. DOI: 10. 1016/j. yexmp. 2011.04. 016.

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部